Medical News

RSS

Impax Laboratories total revenue for second-quarter 2010 increases to $153.1 million

Impax Laboratories, Inc. today reported strong growth in the second quarter of 2010 due to an increase in sales from its Global Product sales channel. Total revenue increased $94.7 million to $153.1 million driven by continued strong sales of generic Adderall XR and generic Flomax for which there were no amounts in the second quarter of 2009, as well as increased sales of the Company's fenofibrate products.

3 Aug 2010

RTI reports second-quarter net income of $10.2M on net sales of $106.7M

RTI International Metals, Inc.,, released results today for the second quarter of 2010.

3 Aug 2010

MAP Pharmaceuticals reports net loss of $12.5M for second-quarter 2010

MAP Pharmaceuticals, Inc. today announced financial results for the second quarter ended June 30, 2010.

3 Aug 2010

Sangon Biotech, Bio Basic complete $10 million round of funding from Qiming Ventures

Sangon Biotech, a Shanghai based life science research service company, and Bio Basic Inc. (BBI), a Toronto based life science research service company, announced today the completion of a $10 million round of funding from Qiming Ventures. The company is using the funding to scale research & development, marketing and sales of its life science research tools including biochemical reagents, protein, antibody, research kit, DNA synthesis service, etc. to meet increasing demand.

3 Aug 2010

EMSC second-quarter net revenue increases 11.2% to $708.8 million

Emergency Medical Services Corporation today announces results for the second quarter ended June 30, 2010.

3 Aug 2010

POZEN reports $16.2M net income for second-quarter 2010

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2010.

3 Aug 2010

AGA Medical second-quarter 2010 net sales increase 7.6% to $53.8 million

AGA Medical Holdings, Inc., a leading developer of interventional medical devices for the minimally invasive treatment of structural heart defects and vascular abnormalities, today reported financial results for the second quarter ended June 30, 2010.

3 Aug 2010

ImpactRx launches smart-phone application for physicians

ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.

3 Aug 2010

Curis reports net loss of $2.1 million for second-quarter 2010

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2010.

3 Aug 2010

STERIS first-quarter revenues increase 3% to $291.3 million

STERIS Corporation today announced financial results for its fiscal 2011 first quarter ended June 30, 2010. During the first quarter, the Company recorded the previously announced liability related to the SYSTEM 1 Rebate Program. Of the $110 million pre-tax amount recorded, $102 million is attributable to the Customer Rebate portion of the Program and was recorded as a reduction of revenues, and $8 million is attributable to the disposal of the SYSTEM 1 units to be returned and was recorded as an increase in cost of revenues.

3 Aug 2010

Kopin second-quarter total sales increase 7.0% to $30.2 million

Kopin Corporation today announced financial results for the second quarter ended June 26, 2010.

3 Aug 2010

Rigel reports net income of $27.0M for second-quarter 2010

Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2010.

3 Aug 2010

Advocate Health Care deploys Fusionfx physician portal

More than 5,000 physicians at Advocate Health Care, the largest fully integrated not-for-profit healthcare delivery system in Illinois, will have streamlined access to patient information across Advocate's 11 Chicago-area hospitals with the implementation of Fusionfx, a portal-based workflow solution from Carefx Corporation.

3 Aug 2010

Tenet Healthcare second-quarter adjusted EBITDA increases 8.9% to $268 million

Tenet Healthcare Corporation today reported adjusted EBITDA of $268 million for the quarter ended June 30, 2010, an increase of $22 million, or 8.9 percent, as compared to $246 million for the second quarter of 2009. Net income attributable to common shareholders for the second quarter of 2010 was $25 million, or $0.05 per diluted share, compared to a net loss of $15 million, or $0.03 per diluted share, for the second quarter of 2009.

3 Aug 2010

Celsion reports net loss of $2.6M for second-quarter 2010

Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.

3 Aug 2010

Titan completes 60% enrollment in confirmatory Phase 3 clinical study of Probuphine for opioid addiction

Titan Pharmaceuticals, Inc. today announced that patient enrollment is more than 60% complete in the confirmatory Phase 3 clinical study of Probuphine for the treatment of opioid addiction, and the study is expected to complete enrollment by early fourth quarter of this year, which is almost three months ahead of schedule.

3 Aug 2010

Dental school students receive grants for showing outstanding leadership abilities

Sixty-one outstanding dental school students received nearly a quarter of a million dollars in grants this year from Delta Dental of California, Delta Dental of Pennsylvania and affiliated companies, officials announced today.

3 Aug 2010

West Pharmaceutical Services second-quarter gross profit increases 5.8% to $83.2 million

West Pharmaceutical Services, Inc. today announced its financial results for the second quarter of 2010.

3 Aug 2010

Caliper Life Sciences second-quarter GAAP revenue decreases 10% to $29.0 million

Caliper Life Sciences, Inc., today reported results for its second quarter ended June 30, 2010. Second quarter GAAP revenue decreased 10% to $29.0 million from $32.1 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 4% on a reported basis and 6% on an organic basis (which assumes constant currency).

3 Aug 2010

First Edition: August 3, 2010

Today's headlines include reports about a federal judge's ruling regarding the Virginia challenge to the health reform law and about the Senate's latest delay in consideration of a state aid package that includes Medicaid assistance.

3 Aug 2010